Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Pluristem Completes Large Scale Cell Therapy Formulation for Commercial and ... 

 

Pluristem Completes Large Scale Cell Therapy Formulation for Commercial and ...
Equities.com
7, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today the Company has successfully completed the integration and testing of its new scaled-up ...

 

Posted on 13-Nov-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: